Protein Kinase C α Is a Central Signaling Node and Therapeutic Target for Breast Cancer Stem Cells

Wai Leong Tam, Haihui Lu, Joyce Buikhuisen, Boon Seng Soh, Elgene Lim, Ferenc Reinhardt, Zhenhua Jeremy Wu, Jordan A. Krall, Brian Bierie, Wenjun Guo, Xi Chen, Xiaole Shirley Liu, Myles Brown, Bing Lim, Robert A. Weinberg

Research output: Contribution to journalArticle

160 Citations (Scopus)

Abstract

The epithelial-mesenchymal transition program becomes activated during malignant progression and can enrich for cancer stem cells (CSCs). We report that inhibition of protein kinase C α (PKCα) specifically targets CSCs but has little effect on non-CSCs. The formation of CSCs from non-stem cells involves a shift from EGFR to PDGFR signaling and results in the PKCα-dependent activation of FRA1. We identified an AP-1 molecular switch in which c-FOS and FRA1 are preferentially utilized in non-CSCs and CSCs, respectively. PKCα and FRA1 expression is associated with the aggressive triple-negative breast cancers, and the depletion of FRA1 results in a mesenchymal-epithelial transition. Hence, identifying molecular features that shift between cell states can be exploited to target signaling components critical to CSCs.

Original languageEnglish (US)
Pages (from-to)347-364
Number of pages18
JournalCancer Cell
Volume24
Issue number3
DOIs
StatePublished - Sep 9 2013

Fingerprint

Neoplastic Stem Cells
Protein Kinase C
Breast Neoplasms
Epithelial-Mesenchymal Transition
Stem Cells
Triple Negative Breast Neoplasms
Therapeutics
Transcription Factor AP-1

ASJC Scopus subject areas

  • Cancer Research
  • Cell Biology
  • Oncology

Cite this

Tam, W. L., Lu, H., Buikhuisen, J., Soh, B. S., Lim, E., Reinhardt, F., ... Weinberg, R. A. (2013). Protein Kinase C α Is a Central Signaling Node and Therapeutic Target for Breast Cancer Stem Cells. Cancer Cell, 24(3), 347-364. https://doi.org/10.1016/j.ccr.2013.08.005

Protein Kinase C α Is a Central Signaling Node and Therapeutic Target for Breast Cancer Stem Cells. / Tam, Wai Leong; Lu, Haihui; Buikhuisen, Joyce; Soh, Boon Seng; Lim, Elgene; Reinhardt, Ferenc; Wu, Zhenhua Jeremy; Krall, Jordan A.; Bierie, Brian; Guo, Wenjun; Chen, Xi; Liu, Xiaole Shirley; Brown, Myles; Lim, Bing; Weinberg, Robert A.

In: Cancer Cell, Vol. 24, No. 3, 09.09.2013, p. 347-364.

Research output: Contribution to journalArticle

Tam, WL, Lu, H, Buikhuisen, J, Soh, BS, Lim, E, Reinhardt, F, Wu, ZJ, Krall, JA, Bierie, B, Guo, W, Chen, X, Liu, XS, Brown, M, Lim, B & Weinberg, RA 2013, 'Protein Kinase C α Is a Central Signaling Node and Therapeutic Target for Breast Cancer Stem Cells', Cancer Cell, vol. 24, no. 3, pp. 347-364. https://doi.org/10.1016/j.ccr.2013.08.005
Tam, Wai Leong ; Lu, Haihui ; Buikhuisen, Joyce ; Soh, Boon Seng ; Lim, Elgene ; Reinhardt, Ferenc ; Wu, Zhenhua Jeremy ; Krall, Jordan A. ; Bierie, Brian ; Guo, Wenjun ; Chen, Xi ; Liu, Xiaole Shirley ; Brown, Myles ; Lim, Bing ; Weinberg, Robert A. / Protein Kinase C α Is a Central Signaling Node and Therapeutic Target for Breast Cancer Stem Cells. In: Cancer Cell. 2013 ; Vol. 24, No. 3. pp. 347-364.
@article{4138d7025787441e8bdf45e107822b3d,
title = "Protein Kinase C α Is a Central Signaling Node and Therapeutic Target for Breast Cancer Stem Cells",
abstract = "The epithelial-mesenchymal transition program becomes activated during malignant progression and can enrich for cancer stem cells (CSCs). We report that inhibition of protein kinase C α (PKCα) specifically targets CSCs but has little effect on non-CSCs. The formation of CSCs from non-stem cells involves a shift from EGFR to PDGFR signaling and results in the PKCα-dependent activation of FRA1. We identified an AP-1 molecular switch in which c-FOS and FRA1 are preferentially utilized in non-CSCs and CSCs, respectively. PKCα and FRA1 expression is associated with the aggressive triple-negative breast cancers, and the depletion of FRA1 results in a mesenchymal-epithelial transition. Hence, identifying molecular features that shift between cell states can be exploited to target signaling components critical to CSCs.",
author = "Tam, {Wai Leong} and Haihui Lu and Joyce Buikhuisen and Soh, {Boon Seng} and Elgene Lim and Ferenc Reinhardt and Wu, {Zhenhua Jeremy} and Krall, {Jordan A.} and Brian Bierie and Wenjun Guo and Xi Chen and Liu, {Xiaole Shirley} and Myles Brown and Bing Lim and Weinberg, {Robert A.}",
year = "2013",
month = "9",
day = "9",
doi = "10.1016/j.ccr.2013.08.005",
language = "English (US)",
volume = "24",
pages = "347--364",
journal = "Cancer Cell",
issn = "1535-6108",
publisher = "Cell Press",
number = "3",

}

TY - JOUR

T1 - Protein Kinase C α Is a Central Signaling Node and Therapeutic Target for Breast Cancer Stem Cells

AU - Tam, Wai Leong

AU - Lu, Haihui

AU - Buikhuisen, Joyce

AU - Soh, Boon Seng

AU - Lim, Elgene

AU - Reinhardt, Ferenc

AU - Wu, Zhenhua Jeremy

AU - Krall, Jordan A.

AU - Bierie, Brian

AU - Guo, Wenjun

AU - Chen, Xi

AU - Liu, Xiaole Shirley

AU - Brown, Myles

AU - Lim, Bing

AU - Weinberg, Robert A.

PY - 2013/9/9

Y1 - 2013/9/9

N2 - The epithelial-mesenchymal transition program becomes activated during malignant progression and can enrich for cancer stem cells (CSCs). We report that inhibition of protein kinase C α (PKCα) specifically targets CSCs but has little effect on non-CSCs. The formation of CSCs from non-stem cells involves a shift from EGFR to PDGFR signaling and results in the PKCα-dependent activation of FRA1. We identified an AP-1 molecular switch in which c-FOS and FRA1 are preferentially utilized in non-CSCs and CSCs, respectively. PKCα and FRA1 expression is associated with the aggressive triple-negative breast cancers, and the depletion of FRA1 results in a mesenchymal-epithelial transition. Hence, identifying molecular features that shift between cell states can be exploited to target signaling components critical to CSCs.

AB - The epithelial-mesenchymal transition program becomes activated during malignant progression and can enrich for cancer stem cells (CSCs). We report that inhibition of protein kinase C α (PKCα) specifically targets CSCs but has little effect on non-CSCs. The formation of CSCs from non-stem cells involves a shift from EGFR to PDGFR signaling and results in the PKCα-dependent activation of FRA1. We identified an AP-1 molecular switch in which c-FOS and FRA1 are preferentially utilized in non-CSCs and CSCs, respectively. PKCα and FRA1 expression is associated with the aggressive triple-negative breast cancers, and the depletion of FRA1 results in a mesenchymal-epithelial transition. Hence, identifying molecular features that shift between cell states can be exploited to target signaling components critical to CSCs.

UR - http://www.scopus.com/inward/record.url?scp=84883621632&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84883621632&partnerID=8YFLogxK

U2 - 10.1016/j.ccr.2013.08.005

DO - 10.1016/j.ccr.2013.08.005

M3 - Article

VL - 24

SP - 347

EP - 364

JO - Cancer Cell

JF - Cancer Cell

SN - 1535-6108

IS - 3

ER -